Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis.

Borgen PO, Dahl OE, Reikerås O.

Clin Orthop Relat Res. 2012 Sep;470(9):2591-8. doi: 10.1007/s11999-012-2320-9. Epub 2012 Apr 3.

2.

Preoperative versus postoperative initiation of dalteparin thromboprophylaxis in THA.

Borgen PO, Dahl OE, Reikeras O.

Hip Int. 2010 Jul-Sep;20(3):301-7.

PMID:
20640994
3.

Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.

Charoencholvanich K, Siriwattanasakul P.

Clin Orthop Relat Res. 2011 Oct;469(10):2874-80. doi: 10.1007/s11999-011-1874-2. Epub 2011 Apr 22.

4.

Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.

Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.

Spine (Phila Pa 1976). 2008 Nov 15;33(24):2577-80. doi: 10.1097/BRS.0b013e318188b9c5.

PMID:
19011538
5.

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.

Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R.

Arch Intern Med. 2000 Jul 24;160(14):2199-207.

PMID:
10904464
6.
7.
8.

Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.

Clavé A, Fazilleau F, Dumser D, Lacroix J.

Orthop Traumatol Surg Res. 2012 Sep;98(5):484-90. doi: 10.1016/j.otsr.2011.12.005. Epub 2012 Apr 27.

9.

Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.

Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS.

Clin Orthop Relat Res. 2014 May;472(5):1552-7. doi: 10.1007/s11999-013-3446-0. Epub 2014 Jan 3.

10.

[A prospective randomized study of wound drainage versus non-drainage in primary total hip or knee arthroplasty].

Mengal B, Aebi J, Rodriguez A, Lemaire R.

Rev Chir Orthop Reparatrice Appar Mot. 2001 Feb 1;87(1):29-39. French.

PMID:
11240535
11.

[A strategy for reduction of blood loss in total hip joint endoprosthesis].

Svagr M.

Acta Chir Orthop Traumatol Cech. 2002;69(4):229-35. Czech.

PMID:
12362625
13.

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.

Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R.

Arch Intern Med. 2000 Jul 24;160(14):2208-15.

PMID:
10904465
14.

Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.

Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR.

Clin Orthop Relat Res. 2012 Sep;470(9):2605-12. doi: 10.1007/s11999-012-2310-y. Epub 2012 Mar 15.

15.

The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia.

Kazemi SM, Mosaffa F, Eajazi A, Kaffashi M, Daftari Besheli L, Bigdeli MR, Zanganeh RF.

Orthopedics. 2010 Jan;33(1):17. doi: 10.3928/01477447-20091124-30.

PMID:
20055345
16.

Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.

Raskob G, Cohen AT, Eriksson BI, Puskas D, Shi M, Bocanegra T, Weitz JI.

Thromb Haemost. 2010 Sep;104(3):642-9. doi: 10.1160/TH10-02-0142. Epub 2010 Jun 29.

PMID:
20589317
17.

Can an Arthroplasty Registry Help Decrease Transfusions in Primary Total Joint Replacement? A Quality Initiative.

Markel DC, Allen MW, Zappa NM.

Clin Orthop Relat Res. 2016 Jan;474(1):126-31. doi: 10.1007/s11999-015-4470-z. Erratum in: Clin Orthop Relat Res. 2016 Jan;474(1):279.

PMID:
26215083
18.

Blood loss and transfusion rate in noncemented and cemented/hybrid total hip arthroplasty. Is there a difference? A comparison of 25 matched pairs.

Trice ME, Walker RH, D'Lima DD, Morris BA, Colwell CW Jr.

Orthopedics. 1999 Jan;22(1 Suppl):s141-4.

PMID:
9927115
19.

Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis.

Gill SK, Theodorides A, Smith N, Maguire E, Whitehouse SL, Rigby MC, Ivory JP.

Hip Int. 2011 Nov-Dec;21(6):678-83. doi: 10.5301/HIP.2011.8842.

PMID:
22117258
20.

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

Lassen MR, Borris LC, Anderson BS, Jensen HP, Skejø Bro HP, Andersen G, Petersen AO, Siem P, Hørlyck E, Jensen BV, Thomsen PB, Hansen BR, Erin-Madsen J, Møller JC, Rotwitt L, Christensen F, Nielsen JB, Jørgensen PS, Paaske B, Tørholm C, Hvidt P, Jensen NK, Nielsen AB, Appelquist E, Tjalve E, et al.

Thromb Res. 1998 Mar 15;89(6):281-7.

PMID:
9669750
Items per page

Supplemental Content

Write to the Help Desk